皇家华人

Global biotechnology company Biocatalysts Ltd is accessing cutting-edge bioprocessing technology developed at 皇家华人 to gain market advantage.

Biocatalysts manufactures off-the-shelf and speciality enzymes for top food, flavour and pharmaceutical companies. Their products are a vital part of the production process for their customers, who benefit in particular from Biocatalysts鈥� ability to develop customised enzymes rapidly and at low cost.

To streamline their processing capabilities further, the company embarked on a Knowledge Transfer Partnership (KTP) project in 2018 with UCL鈥檚 Department of Biochemical Engineering.

The project has given Biocatalysts access to revolutionary new bioprocessing technology, developed by UCL researchers, which significantly accelerates the development of their enzymes.

Opening the door to world-leading technology

鈥淭he Ultra Scale-Down (USD) kompAs鈩� device we鈥檝e developed at 皇家华人 allows us to mimic the forces that enzymes are exposed to in large-scale operations, using just millilitres of materials. This has many benefits for a company such as Biocatalysts as it allows them to test and evolve enzyme processes in a lab environment, removing the need for expensive, large-scale testing,鈥� explains Dr Andrea Rayat, Associate Professor听in Bioseparations at 皇家华人. Andrea was the academic advisor on the KTP, working听alongside Professor Michael Hoare.

During the two year-project, Biocatalysts and UCL experts collaborated closely to integrate this new technology into Biocatalysts' business. As well as access to the tool itself, Biocatalysts benefitted from UCL鈥檚 advanced biochemical engineering expertise, including training, process design, rapid prototyping and 3D printing.

鈥淲hen we started the KTP project with UCL, we were keen to investigate and ideally implement new technologies that could benefit our development and manufacturing capabilities,鈥� explains Craig Galeozzie, Biocatalysts鈥� Director of Operations.

鈥淭he project proved extremely successful and had an immediate influence on our internal process scale-up methodologies. Furthermore, the process efficiency improvements and commercial benefits aligned to the project are now fully integrated within our manufacturing procedures. It鈥檚 been a very productive and rewarding project for all involved, once again proving how true academic research can influence and ultimately benefit modern industry.鈥�

Cementing Biocatalysts鈥� position as a world-leading specialist

Since working on the KTP, Biocatalysts have embedded UCL biochemical engineering expertise into their practices. 鈥淎s well as significantly streamlining the way we work, we鈥檝e been able to use this new technology to develop new enzymes that result in milder, less energy-intensive manufacturing processes for our customers. We鈥檙e now looking to double our manufacturing capacity again, as a result of the efficiencies achieved using this new tool,鈥� explains KTP Associate Davy Rowan.

The significant progress achieved on the KTP has led to UCL and Biocatalysts being recognised in the IChemE Global Awards 2020. The team were winners in the Food & Drink Category and finalists in the Biochemical Engineering Category. They鈥檝e also been selected as finalists in the Engineering Excellence category of the KTP Awards, Best of the Best 2021.

Building on a strong relationship

As for what鈥檚 next, Biocatalysts are keen to keep their culture of continuous improvement going. They鈥檝e recruited their KTP Associate, who acted as the interface between the company and university, into a new Process Improvement Specialist role.

鈥淲orking with Biocatalysts beyond the KTP means we can keep the momentum going in terms of knowledge transfer, and implement more cutting-edge downstream processing techniques from UCL experts,鈥� adds Davy.

Biocatalysts and UCL are also working together in other ways, with Biocatalysts delivering industry seminars, supporting UCL鈥檚 taught programmes and working on joint publications and events. They鈥檙e now exploring the possibility of future KTPs to continue their mutually beneficial relationship.

鈥淲orking with Biocatalysts has been highly advantageous for us as a research team,鈥� adds UCL鈥檚 Dr Rayat. 鈥淢ost importantly, the KTP has helped us verify that our Ultra Scale-Down technology can be incorporated by industry to great positive effect. We鈥檝e seen its potential and the hugely transformative effect it can have on a company first hand.鈥�

The KTP between UCL and Biocatalysts has been supported by UCL Innovation & Enterprise, who helped with applying for funding, setting up the partnership, and the administrative aspects.

Find out more about Dr Andrea Rayat鈥檚 experience as the academic on the KTP project with Biocatalysts.

Links

Find out more about:

• UCL Department of Biochemical Engineering
• KTP Project wins IChemE Global Award 2020
• For businesses - Working on a Knowledge Transfer Partnerships (KTP) with UCL
• For UCL staff - Transform businesses through a Knowledge Transfer Partnership (KTP)

---

Photo听漏听Biocatalysts Ltd